Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection

Transplant Proc. 1993 Apr;25(2):1791-3.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adult
  • Azathioprine / therapeutic use*
  • Bilirubin / blood
  • Biopsy
  • Cyclosporine / blood
  • Cyclosporine / therapeutic use*
  • Drug Resistance
  • Female
  • Graft Rejection / epidemiology
  • Graft Rejection / pathology
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppression Therapy / methods
  • Incidence
  • Liver Transplantation / immunology*
  • Liver Transplantation / pathology
  • Liver Transplantation / physiology
  • Male
  • Middle Aged
  • Prednisone / therapeutic use*
  • Retrospective Studies
  • Tacrolimus / blood
  • Tacrolimus / therapeutic use
  • Time Factors

Substances

  • Cyclosporine
  • Azathioprine
  • Bilirubin
  • Prednisone
  • Tacrolimus